Fortress Biotech Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Seattle WA United States (2006)

Organization Overview

First Clinical Trial
2011
NCT01434693
First Marketed Drug
2006
crotamiton
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Avenue Therapeutics, Inc. | Caelum Biosciences | Checkpoint Therapeutics, Inc. | Coronado Biosciences, Inc. | Cyprium Therapeutics, Inc. | Helocyte | JOURNEY | Journey Medical Corp | Mustang Bio | Mustang Bio, Inc.